XDx blood test for heart-transplant rejection gets FDA clearance

08/27/2008 | FDAnews · Yahoo!

XDx has received FDA approval to market AlloMap, a blood test designed to help doctors monitor potential organ rejection in heart-transplant patients without the need for repeated biopsies. The test uses blood samples to analyze certain genetic information in white blood cells.

View Full Article in:

FDAnews · Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN